Raiders Decline Trade Offers for Maxx Crosby Amid Injury Concerns
The Las Vegas Raiders turned down multiple trade inquiries for defensive end Maxx Crosby despite offseason interest and a failed deal with the Ravens. The team ultimately decided to retain Crosby, who has been limited by knee injuries and underperformed in tackles for loss this season. Pro Football Focus still ranks him as one of the league’s top edge defenders.
The Las Vegas Raiders declined multiple trade offers for defensive end Maxx Crosby during the 2026 NFL season, despite offseason interest and a failed deal with the Baltimore Ravens that would have netted the Raiders two first-round picks. According to NFL insider Jordan Schultz, the team communicated clearly to interested teams that Crosby was not available, even as reports circulated about his potential departure. Crosby’s 2026 campaign has been hampered by ongoing knee injuries, limiting him to just five tackles for loss through nine games—well below his previous career norms—and contributing to a perceived underperformance in statistical output. However, despite these numbers, Pro Football Focus continues to rank him as one of the league’s top edge defenders, assigning him the seventh-highest defensive rating at his position. The trade saga began after Crosby was shut down early in 2025 due to injury, prompting public frustration expressed on social media, which fueled speculation about a potential exit. Although the Ravens initially agreed to the trade, they later backed out citing concerns over Crosby’s long-term health. Despite this, no other teams pursued a deal, and the Raiders ultimately chose to retain their defensive leader. This decision comes as the team has shifted focus to a new offensive identity under quarterback Fernando Mendoza, making it unlikely that key defensive pieces like Crosby would be traded.
The Raiders’ decision to keep Maxx Crosby could signal a broader trend in NFL front offices prioritizing long-term defensive stability over short-term cap flexibility, especially when a player remains highly rated by advanced metrics despite injury setbacks. If Crosby’s performance improves as his health recovers, the team may benefit from retaining a proven edge rusher who still commands respect across the league. Conversely, if his injuries persist, the decision could be seen as a misstep, particularly if other teams capitalize on similar players in future trades. The failed Ravens deal echoes earlier high-profile collapses like the 2019 trade between the Rams and Saints involving Todd Gurley, where health concerns derailed a major move. That case highlighted how medical evaluations can override perceived value. In this instance, the Raiders may be betting on Crosby’s elite defensive rating to justify his retention, even if his stats don’t reflect it. What remains uncertain is whether the team will reconsider trading him if his performance does not improve by mid-season or if new injuries emerge. The broader impact could influence how teams assess injured star players in future trade markets—valuing analytics over raw production—and may affect how players manage their public image during injury recoveries.